Characteristics of adult severe uncontrolled asthma patients in primary care and modifications in prescribed inhalation treatments Visa övriga samt affilieringar
2026 (Engelska) Ingår i: Journal of Asthma and Allergy, ISSN 1178-6965, Vol. 19, artikel-id 585933Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background: Severe asthma outcomes in primary care are poorly documented. This study characterizes adults with severe uncontrolled asthma and evaluates modifications of prescribed inhalation therapy and exacerbations over 12 months.
Methods: Adult primary care asthma patients, with visits recorded in the Swedish National Airway Register from July 2017 to February 2019 (index date), were included. Data were linked to National Prescribed Drug Register. Severe asthma was defined by adherence to high dose inhaled corticosteroids (ICS) ± long-acting beta-agonists (LABA) or ICS+LABA+long-acting muscarinic antagonists. Inhalation therapy was assessed 12 months pre- and post-index. All other variables were collected up to 24 months pre-index and 12 months post-index. Uncontrolled asthma was defined as Asthma Control Test ≤19.
Results: Severe asthma was identified in 2789 patients, of which, 1261 had uncontrolled disease. Severe uncontrolled asthma associated with regular OCS use 24 months pre-index (OR 1.77, 95% CI 1.42–2.20), obesity (1.63, 1.32–2.02), primary school education (1.55, 1.22–1.96) and inversely associated with asthma management education (0.77, 0.66–0.90). Post-index, 5%, 55% and 45% increased, maintained or reduced their inhalation therapy, respectively. Patients increasing inhalation therapy had lower mean FEV1% predicted (67.8 vs. 80.9 and 79.4), more regular OCS uses pre-index (34.8% vs. 17% and 21.9%), and high SABA use (33.3% vs. 27.3% and 21.3%). Post-index asthma exacerbations in severe uncontrolled asthma associated with rhinitis (1.46, 95% CI 1.14–1.88), cardiovascular disease (1.38, 1.06–1.80), high SABA use (1.79, 1.38–2.34), and treatment increase (1.83, 1.08–3.10).
Conclusion: In primary care, severe uncontrolled asthma was among other factors associated with regular OCS use, obesity, lower educational level and absence of asthma management education. Uncontrolled patients already adhering to high dose ICS medication and further increased inhalation therapy were at greater risk of exacerbations, indicating the need for referral to secondary care.
Ort, förlag, år, upplaga, sidor Dove Medical Press, 2026. Vol. 19, artikel-id 585933
Nyckelord [en]
asthma management, inhalation adjustment, treatment outcome
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer URN: urn:nbn:se:umu:diva-251689 DOI: 10.2147/JAA.S585933 ISI: 001719788800001 PubMedID: 41878748 Scopus ID: 2-s2.0-105033293510 OAI: oai:DiVA.org:umu-251689 DiVA, id: diva2:2050607
Forskningsfinansiär AstraZeneca Hjärt-Lungfonden, 2022-0478 Hjärt-Lungfonden, 20230537 Hjärt-Lungfonden, 20230473 Umeå universitet Region Västerbotten Region Stockholm Svenska Frimurare Orden Konsul Th C Berghs Stiftelse för vetenskaplig forskning Astma- och Allergiförbundet 2026-04-022026-04-022026-04-02 Bibliografiskt granskad